Quarterly report pursuant to sections 13 or 15(d)

Common Stock Equivalents

v2.4.0.8
Common Stock Equivalents
6 Months Ended
Jun. 30, 2013
Common Stock Equivalents [Abstract]  
COMMON STOCK EQUIVALENTS
 
8.            COMMON STOCK EQUIVALENTS 
 
SUBSCRIPTION WARRANTS
 
In connection with a private offering initiated on January 28, 2013, the Company issued 4,990,000 shares of its common stock and issued warrants to purchase 4,990,000 shares of its common stock at an exercise price of $2.25 per share to 14 accredited investors during the period of January 28, 2013 through June 11, 2013 for $2,208,000.  The warrants expire three years from the date of issuance and vest immediately.  The amount allocated to the warrants based on the relative fair value of the warrants issued was estimated at approximately $1,772,320  using the Black-Scholes valuation model and the following assumptions: (1) expected volatility of ranging from  140% - 467% based on historical volatility; (2) an interest rate ranging from 0.35% - 0.42%; (3) expected life of 3 years and (4) zero dividend yield.  The fair value of the options were determined based on the respective closing price on the dates of the grants.
 
COMPENSATION AND SERVICE WARRANTS
 
On January 11, 2013, the Board of Directors of the Company approved the Company’s 2013 Omnibus Incentive Plan (the “2013 Plan”), which enables the Company to grant stock options, stock appreciation rights, restricted stock, restricted stock units, phantom stock and dividend equivalent rights to associates, directors, consultants, and advisors of the Company and its affiliates, and to improve the ability of the Company to attract, retain, and motivate individuals upon whom the Company’s sustained growth and financial success depend, by providing such persons with an opportunity to acquire or increase their proprietary interest in the Company. Stock options granted under the Plan may be Non-Qualified Stock Options or Incentive Stock Options, within the meaning of Section 422(b) of the Internal Revenue Code of 1986, except that stock options granted to outside directors and any consultants or advisers providing services to the Company or an affiliate shall in all cases be Non-Qualified Stock Options. The Plan is to be administered by the Board, which shall have discretion over the awards and grants thereunder. The aggregate maximum number of shares of Common Stock for which stock options or awards may be granted pursuant to the Plan is 5,000,000, adjusted as provided in Section 11 of the Plan. The Plan expires on December 1, 2015. The Plan was approved by a majority of the Company’s shareholders on February 13, 2013.    In conjunction with the Plan, the Company recognized compensation expense for the three month and six month period ended June 30, 2013 of $520,321 and $1,039,065.  As of June 30, 2013, there was $5,202,796 of unrecognized expense that will be recognized over 2.5 years.  As of June 30, 2013, 4,350,000 options were outstanding.
 
On January 11, 2013, the Company issued 12,000 options from the 2013 Omnibus Plan at an exercise price of $1.50 per share of the of the Company’s common stock to the Company’s newly appointed Board member as part of his compensation package.  The options vest ratably over two years from date of issuance and expire on January 11, 2018.  The fair value of the options issued on the date of the grant was estimated at $17,880, which will be recognized over the service period, using the Black-Scholes valuation model and the following assumptions: (1) expected volatility of nearly 760% based on historical volatility; (2) an interest rate of 0.43%; (3) expected life of 3.5 years and (4) zero dividend yield.  The stock price was determined based on the closing price on the date of the grant.  
 
During the period of March 22, 2013 through June 12, 2013, the Company issued 848,000 warrants to a shareholder in connection with the procurement of investor capital.  The warrants vest immediately and expire five years from date of issuance; 424,000 warrants have an exercise price of $0.50 and the remaining 424,000 warrants have an exercise price of $2.25.  The fair value of the warrants issued on the date of the grant was estimated at $1,008,457, which was recognized  as a reduction of proceeds from sale of when issued, using the Black-Scholes valuation model and the following assumptions: (1) expected volatility ranging from 142% - 146% based on historical volatility; (2) an interest rate ranging from 0.80% - 1.15%; (3) expected life of 5 years and (4) zero dividend yield.  The stock price was based on the closing price of the stock on the date of the grant.  
 
On April 1, 2013, the Company issued 150,000 options under the 2013 Omnibus Incentive Plan to a company for the procurement of investor capital.  The options expire in five years from date of issuance and have an exercise price of $0.50.  The fair value of the options issued on the date of the grant was estimated at $187,431 which was recognized when issued and netted against proceeds, using the Black-Scholes valuation model and the following assumptions: (1) expected volatility of nearly 435% based on historical volatility; (2) an interest rate of 0.30%; (3) expected life of 2.5 years and (4) zero dividend yield.  The stock price was determined based on the closing price on the date of the grant.  
 
On April 29, 2013, the Company issued 2,200,000 warrants to a company that is owned by the Chief Executive Officer of the Company and is a shareholder of the Company to replace a grant of 2,200,000 warrants which had recently expired.  The warrants vest immediately, expire three years from date of issuance and have an exercise price of $1.31.  The fair value of the warrants issued on the date of the grant was estimated at $2,253,119, which was recognized when issued, using the Black-Scholes valuation model and the following assumptions: (1) expected volatility of 144% based on historical volatility; (2) an interest rate of 0.32%; (3) expected life of 3 years and (4) zero dividend yield.  The stock price was determined based on the closing price on the date of the grant.  
 
The Company recognized compensation cost related to the vesting of these warrants and options for the three and six months ended June 30, 2013 and 2012 of $2,782,260, $142,864, $3,307,423, $236,651 and $4,151,322 for the period of September 3,2009 (inception) to June 30, 2013, respectively.
 
The fair value of all warrant issuances was computed using the Black-Scholes Model, incorporating transaction details such as stock price, contractual terms, maturity and risk free rates, as well as assumptions about future financing, volatility and holder behavior.
 
The following table summarizes outstanding warrants by Expiration Date at June 30, 2013:
 
       
Exercise
 
Expiration
 
Quantity
   
Price
 
Date
 
 
   
   
   
    500,000     $ 10.00  
August 10, 2013
    500,000     $ 7.50  
August 10, 2013
    500,000     $ 5.00  
August 10, 2013
    10,000     $ 51.50  
August 25, 2013
   
4,652,165
    $ 3.00  
August 25, 2013
    1,277,170     $ 1.66
July 13, 2014
    65,000     $ 1.00  
September 14, 2014
    250,000     $ 1.50  
November 15, 2013
    20,000     $ 1.00  
December 2, 2014
    56,000     $ 1.00  
December 11, 2014
    5,000     $ 1.00  
December 28, 2014
    3,834     $ 30.00  
May 5, 2015
    100,000     $ 1.00  
October 10, 2015
    50,000     $ 1.00  
October 12, 2015
    500,000     $ 2.25  
October 25, 2015
    25,000     $ 2.25  
November 14, 2015
    100,000     $ 1.64  
December 13, 2015
    50,000     $ 20.00  
January 11, 2016
    250,000     $ 2.25  
January 23, 2016
    150,000     $ 2.25  
January 25, 2016
    100,000     $ 2.25  
January 28, 2016
    300,000     $ 2.25  
January 30, 2016
    250,000     $ 2.25  
February 5, 2016
    40,000     $ 2.25  
February 21, 2016
    3,500,000     $ 2.25  
March 1, 2016
    200,000     $ 2.25  
March 11, 2016
    5,000     $ 1.75  
March 19, 2016
    200,000     $ 2.25  
March 22, 2016
    2,200,000     $ 1.31  
April 29, 2016
    150,000     $ 2.25  
June 4, 2016
    600,000     $ 2.25  
June 10, 2016
    5,000     $ 1.75  
March 19, 2017
    250,000     $ 1.00  
June 28, 2017
    11,800     $ 1.00  
December 13, 2017
    5,000     $ 1.75  
March 19, 2018
   
329,000
    $ 0.50    March 22, 2018
    329,000     $ 2.25  
March 22, 2018
    80,000     $ 2.25  
June 5, 2018
    80,000     $ 0.50  
June 5, 2018
    15,000     $ 2.25  
June 12, 2018
    15,000     $ 0.50  
June 12, 2018
    100,000     $ 1.00  
September 22, 2018
    17,828,969    
  Total  
   

 
*Price may be lower if market closes at lower price on exercise date.
 
Warrants Outstanding as of June 30, 2013
 
Range of Exercise Price
 
Number
Outstanding
   
Weighted
Average
Contractual Life
(in years)
   
Weighted
Average
Exercise Price
 
                   
$0.50-$51.50
   
17,828,969
     
2.33
   
$
2.70
 
 
Warrants Exercisable as of June 30, 2013
 
Range of Exercise Price
 
Number
Outstanding
   
Weighted
Average
Contractual Life
(in years)
   
Weighted
Average
Exercise Price
 
                   
$1.00-$51.50
   
17,557,168
     
2.28
   
$
2.73